Tesla, Toyota And 3 Stocks To Watch Heading Into Thursday
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 26 2024
0mins
Should l Buy HIT?
Source: Benzinga
iHuman Inc. Financial Results: iHuman reported a net income of RMB25.1 million for Q3, down from RMB51.9 million last year, with revenues falling 8.4% to RMB239.4 million; shares rose 1.1% to $1.7589.
Color Star Technology Surge: Color Star's shares soared 125.9% in pre-market trading after announcing the addition of a UAE royal family member as an independent director, reaching $4.88.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy HIT?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on HIT
Wall Street analysts forecast HIT stock price to rise
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.900
Low
4.50
Averages
4.50
High
4.50
Current: 1.900
Low
4.50
Averages
4.50
High
4.50
About HIT
Health In Tech, Inc. is an Insurtech platform company backed by third-party artificial intelligence technology, which offers a marketplace that aims to improve processes in the healthcare industry through vertical integration, process simplification, and automation. It offers a marketplace designed to create healthcare plan solutions while streamlining processes through vertical integration, process simplification, and automation. Its services are delivered through three subsidiaries: Stone Mountain Risk, LLC (SMR), International Captive Exchange, LLC (ICE), and HI Card LLC’s HI Card platform (HI Card). The SMR is a program manager specializing in customized self-funded programs for small businesses. ICE is a managing general underwriter. ICE assists with underwriting activities through its Web-based SaaS quoting platform, Enhance Do It Yourself Benefit System (eDIYBS). HI Card seeks to simplify healthcare management with a single standardized transaction and service platform.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Earnings Release Schedule: Health In Tech will announce its fourth quarter and full year 2025 financial results after market close on March 25, 2026, enhancing the company's transparency and investor communication.
- Conference Call Details: The company will host a conference call at 5:00 PM ET on the same day, providing dial-in information for participants, which underscores its commitment to investor relations and in-depth financial result analysis.
- Webcast Replay Availability: A replay of the earnings call will be available on the company's investor relations website for approximately 90 days post-call, ensuring that investors can access critical information at their convenience, thereby improving information accessibility.
- Company Overview: Health In Tech is an AI-enabled InsurTech platform focused on streamlining insurance processes in the healthcare industry through simplification and automation, showcasing its innovative capabilities and market potential within the sector.
See More
- Earnings Release Schedule: Health In Tech will announce its fourth quarter and full year 2025 financial results after market close on March 25, 2026, indicating the company's commitment to transparency and investor communication.
- Conference Call Details: The company will host a conference call at 5:00 PM ET on the same day, providing toll-free and international dial-in options, reflecting its focus on investor relations.
- Webcast Replay Availability: A replay of the earnings call will be available on the company's investor relations website for approximately 90 days post-call, enhancing accessibility and transparency of information for stakeholders.
- Company Overview: Health In Tech is an AI-enabled InsurTech platform that aims to improve insurance processes in the healthcare sector through simplification and automation, showcasing its innovative capabilities and market potential in the industry.
See More
- New CTO Appointment: Health In Tech appointed Sri Rajagopalan as Chief Technology Officer effective February 23, 2026, after serving as Interim CTO since November 2025, where he advanced the company's AI transformation strategy and strengthened technology leadership.
- Technology Architecture Optimization: As CTO, Rajagopalan is responsible for advancing the next-generation technology architecture and AI development roadmap, aiming to enhance performance, security, and scalability through cloud-native platforms to support the company's long-term growth strategy.
- Extensive Industry Experience: With over 20 years of enterprise-scale technology leadership, Rajagopalan has held senior roles at SAP and IBM, focusing on healthcare technology, bringing deep expertise in payments and claims technology to Health In Tech.
- Strategic Growth Support: CEO Tim Johnson noted that Rajagopalan's leadership will strengthen the core technology foundation, enabling the expansion of larger-scale underwriting and benefits administration platforms, ensuring the company can execute multiple strategic initiatives for sustainable growth.
See More
- New CTO Appointment: Health In Tech appointed Sri Rajagopalan as Chief Technology Officer effective February 23, 2026, after serving as Interim CTO since November 2025, where he significantly advanced the company's AI-driven transformation strategy and technology leadership.
- Technology Architecture Optimization: As CTO, Rajagopalan is responsible for advancing the next-generation technology architecture and AI development roadmap, aiming to embed artificial intelligence and data intelligence into underwriting, claims, and benefits administration workflows, thereby enhancing operational efficiency and customer experience.
- Cloud-Native Platform Development: His mandate includes building and optimizing the company's cloud-native enterprise-grade platforms to enhance performance, security, and scalability, which will lay a solid foundation for Health In Tech's long-term growth strategy and support larger-scale partnerships.
- Rich Industry Experience: With over 20 years of enterprise-scale technology leadership experience, Rajagopalan has held senior roles at SAP and IBM, and his extensive background will provide robust support for Health In Tech's technology acceleration and product innovation efforts.
See More

- Executive Appointment: Health In Tech has appointed Zain Hasan as Chief Growth Officer, who has played a pivotal role in market execution and distribution expansion since joining in September 2025, and is expected to further enhance the company's revenue performance.
- Growth Strategy: Zain will lead the company's overall growth strategy, focusing on sales, distribution, partnerships, and revenue operations, aiming to enhance market competitiveness and client responsiveness through the AI-powered platform.
- Innovative Products: Health In Tech offers over 100 customized healthcare plan designs bundled with AI-driven underwriting, enabling brokers to generate bindable healthcare plan quotes within minutes, thereby accelerating market response.
- Industry Experience: With over 15 years in the employee benefits and insurance industry, Zain has successfully founded and exited multiple companies, and his extensive background will aid the company in achieving long-term growth objectives and enhancing shareholder value.
See More

- Product Expansion: Health In Tech announces the launch of over 100 customized self-funded healthcare plans, aimed at enhancing brokers' sales efficiency and market responsiveness, thereby strengthening the company's position in the competitive healthcare insurance market.
- Strategic Collaboration: The partnership with Benefit Re integrates advanced cost management and accelerated claims processing, with Benefit Re's 85% employer retention rate demonstrating success in risk management and pricing discipline, further enhancing Health In Tech's market competitiveness.
- Sales Cycle Reduction: Through its AI-driven platform, Health In Tech is able to reduce sales cycles by nearly 90%, which not only enhances brokers' execution capabilities but also allows employers to quickly access the healthcare solutions they need, improving customer satisfaction.
- Long-Term Growth Potential: This expansion not only meets employers' demands for flexible healthcare plans but also creates opportunities for future entry into the property and casualty insurance market, showcasing the company's sustainable growth strategy in the self-funded healthcare sector.
See More






